Drug Shortage Report for TWINRIX JUNIOR
Report ID | 48544 |
Drug Identification Number | 02237548 |
Brand name | TWINRIX JUNIOR |
Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 360UNIT 10MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-05-03 |
Estimated end date | 2019-02-18 |
Actual end date | 2019-02-06 |
Shortage status | Resolved |
Updated date | 2019-02-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.